Qure.ai

We’re on Times Square. What a moment of pride to see Qure.ai on one of the world’s most visible platforms, in the heart of New York. We began with an ambitious vision: to use AI to help solve some of healthcare’s biggest challenges. Today, that vision is being realised across markets and healthcare systems around the world. Seeing Qure.ai on the Nasdaq Tower is a fitting reflection of that growth, and of the ambition behind what we’re building. But it is also a reminder of how much more there is to do. As we take a moment to recognise what we’ve built, we’re equally focused on what comes next. This milestone belongs to everyone who has contributed to the journey, from our teams and partners to the customers and healthcare systems that have trusted us along the way. Proud of what we’ve built together. Humble about the journey so far. Excited about what comes next. Prashant Warier Ankit Modi Bhargava Reddy Bunty Kundnani Javier J Z. Shibu Vijayan Harsh Vaish Malika Shrivastava Mihir Bhanushali Poonam Ajgaonkar Amy Casey Kautuk Trivedi Manoj Tld Pradeep Kumar Thummala Preetham Putha Sagar Sen Samir Shah, MD, MMM FACR #QureAI #AIinHealthcare #TimeSquare #NewYork #US

How is AI doing facial recognition on a whale shark? That’s just one of the many unexpected stories in the latest episode of Early Signs. Dr. Amit Kakar MD, Managing Partner, Head of Novo Holdings Asia, joins Prashant Warier, Co-founder & CEO, Qure.ai, for a wide-ranging conversation on just how far AI could take us from augmenting doctors and changing how investors evaluate companies, to creating digital twins of our health, accelerating drug discovery, and reimagining what patient care could look like. And if facial recognition for whale sharks sounds unexpected, there’s a lot more in this conversation. Catch the full episode: https://lnkd.in/dm74GDTH Also available on Spotify, Apple Podcasts and other major audio streaming platforms. Click below to listen to the podcast:  Spotify: https://lnkd.in/dTNKub8r Apple Podcasts: https://lnkd.in/dvf3iCbs #EarlySignsPodcast #QureAI #AI #AIinHealthcare #DigitalHealth

Health systems facing severe workforce shortages will not train their way out of the problem fast enough. That makes the next question unavoidable: Can an AI Doctor help close the knowledge gap and give every primary health centre access to stronger clinical intelligence, regardless of geography? At UNGA81, we are bringing together leaders from government, technology and global health to ask what it will take to move this from possibility to national-scale reality. Hear from H.E. Budi Sadikin , H.E. Dr. Mekdes Daba Feyssa, MD, MPH, H.E. Dr. Ussene Isse, Tarun Mehra, Dr. Peter Clardy, John Fairhurst, Dr. Ditiu Lucica, Ben Brockman, Melissa Miles and Prashant Warier as they explore what governments should ask AI to solve, what builders can make possible next, and what it will take to deliver that ambition at scale - with Melissa Mahtani moderating the conversation on funding the future and what it will take to scale. Reimagining the Future of Healthcare with AI 24 September | UN Church Center, New York If you are in New York for UNGA, join us.

AI is moving from a point solution to something much more consequential: an intelligence layer that could reshape how care is delivered across entire health systems. For countries facing persistent shortages of doctors, specialists and frontline capacity, that raises a bigger question. What happens when clinical intelligence can travel further than the workforce itself? Reimagining the Future of Healthcare with AI brings together leaders from government, technology and global health to examine what this shift could mean in practice. The discussion will explore: * What governments should ask AI to solve first * How the AI Doctor could extend clinical intelligence across the care journey * What builders can make possible with increasingly capable AI * What it will take to finance these capabilities at national scale Hear perspectives from H.E. Budi Gunadi Sadikin, H.E. Dr. Mekdes Daba, H.E. Dr. Ussene Hilário Isse, Tarun Mehra, Dr. Pete Clardy, John Fairhurst, Dr. Lucica Ditiu and Ben Brockman. The technology is advancing quickly. The conversation now is about what health systems choose to do with it. 24 September 2026 | UN Church Center, New York Time- 5:00 to 6:30pm | Eastern Daylight Time (EDT) : UTC-4 Hosted by Qure.ai alongside UNGA81. By invitation only. Limited seating." RSVP - https://lnkd.in/dxx47tN8

A win for frontline health workers can change patient care everywhere. Aira, Qure.ai’s AI-powered Clinical Decision Support System, is now Class IIb CE certified-making it among the world’s first CDSS platforms to bring clinical decision-making, documentation, workflow automation and EHR analysis together under a single CE mark. Built for frontline health workers, Aira helps turn fragmented records into connected care, guidelines into decisions, and missed appointments into timely follow-up. Because when resources are stretched, every minute returned to a health worker is another minute given back to a patient. This is more than a regulatory milestone. It is a win for the frontline. And a new standard for the care that begins there. #QureAI #Aira #ClinicalAI #PrimaryCare #HealthTech

In the middle of an AI boom, an investor says he wouldn’t invest in a pure AI company. That sounds contradictory. It isn’t. For Dr. Amit Kakar MD, Managing Partner, Head of Novo Holdings Asia, AI isn’t the investment thesis. It’s the enabler. What matters is what it helps a company do better — from improving decisions and productivity to ultimately transforming patient care. In this episode of the Early Signs Podcast , Dr. Amit Kakar joins Prashant Warier, Co-founder & CEO, Qure.ai, to unpack a question that’s becoming increasingly relevant as almost every company becomes an “AI company” When AI is everywhere, what actually makes a company worth investing in? Watch the full conversation here: https://lnkd.in/dh6NuXdq The Early Signs Podcast is now live on all major audio streaming platforms, tap the links below to listen to the podcast: Spotify: https://lnkd.in/dejzmwBs Apple Podcast: https://lnkd.in/dsc-YUCx #EarlySignsPodcast #QureAI #HealthcareAI #HealthTech #AI

A patient's best chance often comes down to one thing: how early their disease was diagnosed. Too often, diagnosis comes late. A small nodule gets missed on a routine scan, and by the time it's found, fewer treatment options remain. AI-powered imaging changes that. It catches what a first read can miss, the same early findings that biopsy and navigation tools are built to act on, giving patients a real shot at treatment while their disease is still easy to manage. Earlier detection means more patients stay eligible for precision procedures, and a stronger, steadier path into the care Intuitive's systems are built for. Meet us at Intuitive 360: 🗓️ September 10–12 | 📍 Orlando, Florida Come find us to talk about what happens before the first step of surgery. #Intuitive360 #PrecisionCare #EarlyDetection #AIImagingBiomarkers #QureAI

How did a disease that was rare just over a century ago become one of the leading causes of cancer-related mortality worldwide? Lung cancer is frequently diagnosed at advanced stages. Symptoms often do not appear until the disease has progressed, and existing diagnostic tools can miss subtle early signs. As a result, many patients are identified when the options for curative intervention are limited. However, late detection should not determine outcomes for a disease that is increasingly treatable when caught early. That’s where AI-enabled imaging biomarkers can help. These biomarkers can identify signals present in routine diagnostic images, such as chest X-rays and CTs. And importantly, this doesn’t require reinventing the way care is delivered. It works with imaging that is already part of everyday clinical workflows. We will be showcasing how this is being translated into practice at #WCLC26 by International Association for the Study of Lung Cancer 📌 Booth #329 | 🗓️ 12–15 September | 📍 COEX Convention & Exhibition Center, Seoul #WCLC #WorldConferenceonLungCancer2026 #LungCancer #EarlyDetectionLungCancer #AiImagingBiomarkers #QureAI

What if the biggest shift in healthcare isn’t just treating disease better but knowing what’s coming before it arrives? In this episode of Early Signs, Dr. Sunil Verma, SVP & Global Head of Oncology at AstraZeneca, sits down with our Co-Founder & CEO, Prashant Warier, for a conversation about where healthcare is headed and the role AI could play in getting us there. From moving beyond “sick care” to more proactive healthcare, to empowering patients and rethinking what earlier intervention could look like, they explore a future that may be closer than we think. So, how close are we and what needs to happen next? Watch the full conversation to hear two leaders in healthcare and AI unpack what the next era of healthcare could really look like. YouTube: https://lnkd.in/dN7ghfmy Early Signs Podcast is now streaming on all major podcast platforms. Spotify: : https://lnkd.in/dNAiqG6r Apple Podcasts: https://lnkd.in/dsc-YUCx #EarlySigns #EarlySignsPodcast #QureAI #AstraZeneca #AIinHealthcare #HealthcareInnovation #FutureOfHealthcare #Oncology #DigitalHealth

Less than 5 days to go until the International Association for the Study of Lung Cancer World Conference on Lung Cancer 2026, and we’re getting ready to answer one critical question: What happens when AI-enabled imaging biomarkers enable early lung cancer detection?  Even today, many lung cancers are detected at advanced stages. Routine chest radiographs can miss subtle, early-stage pulmonary nodules leaving too many patients outside timely diagnostic and treatment pathways. By the time cancer becomes evident, treatment options may be more limited. But AI-enabled imaging biomarkers can identify pulmonary nodules missed on routine chest radiographs, acting as a second set of eyes for clinicians. From accelerating stage shift in lung cancer detection to enabling earlier patient engagement, faster pathway entry, and improved therapy access, AI can significantly improve lung cancer outcomes. Meet us at the IASLC World Conference on Lung Cancer 2026: 🗓️12–15 September |📍Venue: COEX Convention & Exhibition Center, Seoul. to find out how we’re facilitating the full care journey from signal to action. Visit us at Booth #329 to discover how it can help you and your team. #WCLC26 #WorldConferenceonLungCancer2026 #LungCancer #EarlyDetectionLungCancer #AIImagingBiomarkers #QureAI